Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLY NYSE:BVS NASDAQ:SGHT NASDAQ:SIBN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.28-11.5%$1.71$1.32▼$4.98$572.71M2.594.21 million shs9.04 million shsBVSBioventus$6.51-1.2%$7.03$5.81▼$14.38$538.24M0.81385,823 shs281,060 shsSGHTSight Sciences$3.20-5.3%$3.74$2.03▼$6.29$167.58M2.41183,404 shs111,494 shsSIBNSiBone$14.78-6.0%$15.57$11.70▼$20.05$637.62M0.83427,854 shs595,838 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network-4.28%+31.71%+61.95%+42.27%+35.17%BVSBioventus-2.51%-1.79%-9.35%-5.45%-42.55%SGHTSight Sciences-2.59%+2.11%-5.32%-0.88%-40.39%SIBNSiBone+3.35%+9.85%-2.00%-8.60%+22.43%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.28-11.5%$1.71$1.32▼$4.98$572.71M2.594.21 million shs9.04 million shsBVSBioventus$6.51-1.2%$7.03$5.81▼$14.38$538.24M0.81385,823 shs281,060 shsSGHTSight Sciences$3.20-5.3%$3.74$2.03▼$6.29$167.58M2.41183,404 shs111,494 shsSIBNSiBone$14.78-6.0%$15.57$11.70▼$20.05$637.62M0.83427,854 shs595,838 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network-4.28%+31.71%+61.95%+42.27%+35.17%BVSBioventus-2.51%-1.79%-9.35%-5.45%-42.55%SGHTSight Sciences-2.59%+2.11%-5.32%-0.88%-40.39%SIBNSiBone+3.35%+9.85%-2.00%-8.60%+22.43%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 2.40Hold$3.0031.87% UpsideBVSBioventus 2.75Moderate Buy$13.75111.21% UpsideSGHTSight Sciences 2.25Hold$4.3335.42% UpsideSIBNSiBone 2.50Moderate Buy$23.6760.13% UpsideCurrent Analyst Ratings BreakdownLatest SGHT, SIBN, BFLY, and BVS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/8/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025SGHTSight SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/8/2025SIBNSiBoneWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)10/7/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$4.50 ➝ $4.009/27/2025BFLYButterfly NetworkWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025SGHTSight SciencesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025SIBNSiBoneWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)8/28/2025SGHTSight SciencesNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold8/21/2025SGHTSight SciencesCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$3.60 ➝ $4.508/11/2025SIBNSiBoneCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetOverweight$25.008/8/2025SGHTSight SciencesLake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.00 ➝ $5.00(Data available from 10/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$82.06M6.98N/AN/A$0.79 per share2.88BVSBioventus$564.14M0.95$0.52 per share12.58$2.80 per share2.33SGHTSight Sciences$79.87M2.10N/AN/A$1.72 per share1.86SIBNSiBone$185.26M3.44N/AN/A$3.98 per share3.71Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%11/7/2025 (Estimated)BVSBioventus-$156.23MN/AN/A14.15N/A-7.11%15.61%4.01%N/ASGHTSight Sciences-$51.51M-$0.96N/AN/AN/A-64.23%-59.38%-36.43%11/6/2025 (Estimated)SIBNSiBone-$30.91M-$0.56N/AN/AN/A-12.83%-14.20%-10.38%11/11/2025 (Estimated)Latest SGHT, SIBN, BFLY, and BVS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/7/2025Q3 2025BFLYButterfly Network-$0.07N/AN/AN/AN/AN/A11/6/2025Q3 2025SGHTSight Sciences-$0.26N/AN/AN/AN/AN/A8/7/2025Q2 2025SGHTSight Sciences-$0.25-$0.23+$0.02-$0.23$18.18 million$19.56 million8/4/2025Q2 2025SIBNSiBone-$0.19-$0.14+$0.05-$0.14$48.12 million$48.63 million8/1/2025Q2 2025BFLYButterfly Network-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/ABVSBioventusN/AN/AN/AN/AN/ASGHTSight SciencesN/AN/AN/AN/AN/ASIBNSiBoneN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A5.684.14BVSBioventus1.851.410.99SGHTSight Sciences0.5710.019.49SIBNSiBone0.218.387.00Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%BVSBioventus62.94%SGHTSight Sciences55.51%SIBNSiBone98.11%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network25.18%BVSBioventus33.00%SGHTSight Sciences30.90%SIBNSiBone4.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460251.74 million188.35 millionOptionableBVSBioventus1,20082.68 million54.46 millionNot OptionableSGHTSight Sciences21052.37 million36.19 millionOptionableSIBNSiBone35043.14 million41.42 millionOptionableSGHT, SIBN, BFLY, and BVS HeadlinesRecent News About These CompaniesSiBone (NASDAQ:SIBN) Receives "Sell (D-)" Rating from Weiss RatingsOctober 9 at 3:51 AM | marketbeat.comSiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,128 SharesOctober 7 at 4:34 AM | insidertrades.comSiBone (NASDAQ:SIBN) SVP Michael Pisetsky Sells 3,128 SharesOctober 6, 2025 | marketbeat.comAnshul Maheshwari Sells 3,311 Shares of SiBone (NASDAQ:SIBN) StockOctober 6, 2025 | marketbeat.comInsider Selling: SiBone (NASDAQ:SIBN) Insider Sells 3,311 Shares of StockOctober 6, 2025 | marketbeat.comDATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of SI-Bone, Inc. Customers Whose Data May Have Been CompromisedOctober 3, 2025 | globenewswire.comSiBone (NASDAQ:SIBN) Stock Price Down 4.2% - Here's WhyOctober 1, 2025 | marketbeat.comSiBone (NASDAQ:SIBN) versus RxSight (NASDAQ:RXST) Critical ReviewOctober 1, 2025 | americanbankingnews.comPalumbo Wealth Management LLC Buys Shares of 30,649 SiBone $SIBNSeptember 25, 2025 | marketbeat.comHarbor Capital Advisors Inc. Raises Stake in SiBone $SIBNSeptember 17, 2025 | marketbeat.comSiBone $SIBN Shares Bought by Goldman Sachs Group Inc.September 17, 2025 | marketbeat.comSI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 9, 2025 | seekingalpha.comSI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025August 26, 2025 | globenewswire.comSiBone (NASDAQ:SIBN) SVP Sells $52,065.56 in StockAugust 21, 2025 | insidertrades.comInsider Selling: SiBone (NASDAQ:SIBN) Director Sells 12,132 Shares of StockAugust 12, 2025 | insidertrades.comSI-Bone Reports Strong Q2 2025 Financial ResultsAugust 5, 2025 | msn.comSI-BONE, Inc. (SIBN) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comSI-BONE, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.comSi-Bone (SIBN) Reports Q2 Loss, Beats Revenue EstimatesAugust 4, 2025 | zacks.comSI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 GuidanceAugust 4, 2025 | globenewswire.comSI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025July 29, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSGHT, SIBN, BFLY, and BVS Company DescriptionsButterfly Network NYSE:BFLY$2.28 -0.30 (-11.48%) Closing price 03:59 PM EasternExtended Trading$2.22 -0.05 (-2.20%) As of 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.Bioventus NYSE:BVS$6.51 -0.08 (-1.21%) Closing price 04:00 PM EasternExtended Trading$6.53 +0.02 (+0.31%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Bioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.Sight Sciences NASDAQ:SGHT$3.20 -0.18 (-5.33%) Closing price 04:00 PM EasternExtended Trading$3.20 +0.00 (+0.16%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.SiBone NASDAQ:SIBN$14.78 -0.94 (-5.98%) Closing price 04:00 PM EasternExtended Trading$14.79 +0.01 (+0.07%) As of 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally PepsiCo’s Deep Discount Will Soon Evaporate: Buy It While You Can Bargain Alert: DraftKings Is the Most Oversold It’s Ever Been Constellation Brands: Buffett’s $2.2B Bet May Have Hit Bottom How Gamers Are Powering Microsoft’s Next Wave of Growth AI Meets Nuclear: Palantir’s Role in Energy Expansion Buy the Dip? Zillow’s Profit Comeback Meets Market Pressure Adobe Launches Premiere Pro on iPhone, Upside Ahead? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
